Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Gynecologic malignancies]

¹Department of Obstetrics and Gynecology, Yamaguchi University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|June 1, 1996

Summary

This summary is machine-generated.

Tumor markers like SCC antigen and CA125 are crucial for gynecologic cancers. Understanding their biological functions may lead to new diagnostic and therapeutic strategies for these malignancies.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adenosine A2 receptor antagonist facilitates the reversal of long-term potentiation (depotentiation) of evoked postsynaptic potentials but inhibits that of population spikes in hippocampal CA1 neurons.

Neuroscience letters·1992

Same author

The helix-loop-helix/leucine repeat transcription factor USF can be functionally regulated in a redox-dependent manner.

The Journal of biological chemistry·1992

Same author

Immunohistochemical study of the histogenesis of esophageal carcinosarcoma.

Japanese journal of clinical oncology·1992

Same author

Structure and distribution of the lymphatic vessels in the parietal pleura of the monkey as studied by enzyme-histochemistry and by light and electron microscopy.

Archives of histology and cytology·1992

Same author

Specific expressions of Fyn and Lyn, lymphocyte antigen receptor-associated tyrosine kinases, in the central nervous system.

Brain research. Molecular brain research·1992

Same author

A hyperpolarizing response induced by glutamate in mouse cerebellar Purkinje cells.

Neuroscience research·1992

Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019

See all related articles

Area of Science:

Oncology
Biochemistry

Context:

Gynecologic malignancies represent a significant health concern.
Current diagnostic and therapeutic strategies require continuous improvement.

Purpose:

To discuss the clinical value of tumor markers in gynecologic malignancies.
To explore their potential future roles in diagnosis and therapy.

Summary:

Squamous cell carcinoma (SCC) antigen and CA125 are primary tumor markers for specific gynecologic cancers.
Emerging research on the biological functions of SCC antigen, such as cysteine protease inhibition, offers insights into tumor cell behavior.

Impact:

New information on tumor marker function can inform the development of novel diagnostic tools.

Understanding biological roles may facilitate the creation of innovative therapeutic approaches for gynecologic cancers.